Dysphagia Secondary to a Solitary Plasmacytoma

Abstract

Get full access to this article

View all access options for this article.

References

Hernandez

J.A.

, Land

K.J.

, McKenna

R.W.

Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer. 1995; 75: 381–394.

Osserman

E.F.

Plasma cell myeloma: II. Clinical aspects. N Engl J Med. 1959; 261: 952–960.

Bolek

T.W.

, Marcus

R.B.

, Mendenhall

N.P.

Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996; 36: 329–333.

Knowling

M.A.

, Harwood

A.R.

, Bergsagel

D.E.

Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol. 1983; 1: 255–262.

Bataille

, Sany

Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981; 48: 845–851.

Frassica

D.A.

, Frassica

F.S.

, Schray

M.F.

Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989; 16: 43–48.

Mill

W.B.

, Griffith

The role of radiation therapy in the management of plasma cell tumors. Cancer. 1980; 45: 647–652.

Moulopoulos

L.A.

, Dimopoulos

M.A.

, Weber

Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol. 1993; 11: 1311–1315.

Moulopoulos

L.A.

, Dimopoulos

M.A.

Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood. 1997; 90: 2127–2147.

10.

Moossy

, Wilson

C.B.

Solitary intracranial plasmacytoma. Arch Neurol. 1967; 16: 212–216.

11.

Wasserman

T.H.

Diagnosis and management of plasmacytomas. Oncology. 1987; 1: 37–41.

12.

Dimopoulos

M.A.

, Goldstein

, Fuller

Curability of solitary bone plasmacytoma. J Clin Oncol. 1992; 10: 587–590.

13.

Frassica

F.J.

, Beabout

J.W.

, Unni

K.K.

Myeloma of bone. Orthopedics. 1985; 8: 1184–1186.

14.

Mayr

N.A.

, Wen

B.C.

, Hussey

D.H.

The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990; 17: 293–303.

15.

Holland

, Trenkner

D.A.

, Wasserman

T.H.

Plasmacytoma: treatment results and conversion to myeloma. Cancer. 1992; 69: 1513–1517.

16.

Dimopoulos

M.A.

, Moulopoulos

, Smith

Risk of disease progression in asymptomatic multiple myeloma. Am J Med. 1993; 94: 57–61.

17.

Delauche-Cavallier

M.C.

, Laredo

J.D.

, Wybier

Solitary plasmacytoma of the spine: long-term clinical course. Cancer. 1988; 61: 1707–1714.

18.

Alexanian

, Gutterman

, Levy

Interferon treatment for multiple myeloma. Clin Haematol. 1982; 11: 211–220.

19.

Mandelli

, Avvisati

, Amadori

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N Engl J Med. 1990; 322: 1430–1434.

20.

Clarke

Cranial and intracranial myelomas. Brain. 1954; 77: 61–81.